Vicriviroc, a CCR5 Inhibitor, Added to an Optimized Antiretroviral Therapy for Previously Treated HIV (VICTOR-E2) (Study P04285

Clinical trial NCT00243568 · WITHDRAWN

Trial details

NCT number: NCT00243568
Sponsor: Merck Sharp & Dohme LLC
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

HIV Infections Acquired Immunodeficiency Syndrome

Start date: 2005-09-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.